Figure 1From: Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey Diagram of the randomized double-blind, placebo-controlled cross-over study design.Back to article page